Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Johnson & Johnson (

Asian benchmarks mixed as markets await Fed rate moves

Asian shares are mixed while Chinese shares surged ahead of a decision by the U.S. Federal Reserve on an interest rate increase to curb inflation

The Independent UK

What Biden's 'Windfall of War' Mean for Markets As FOMC Meeting Kicks Off

As all eyes begin to turn to the Federal Reserve, watch the latest news on Biden's threat to big oil, earnings from Pfizer and Uber and much more live at 9:30 a.m. ET.

The Street

Abiomed Stock Soars After $16.6 Billion Johnson & Johnson Takeover Amid Deeper Medical Devices Push

"The addition of Abiomed is an important step in our vision for the new Johnson & Johnson focused on Pharmaceutical and MedTech," said CEO Joaquin Duato.

The Street

From analysis to the latest developments in health,
read the most diverse news in one place.

Johnson & Johnson Whale Trades Spotted

Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

United Airlines, Johnson & Johnson And 2 Other Stocks Insiders Are Selling

US crude oil futures traded lower on Monday. Investors, meanwhile, focused on some notable insider trades.

Benzinga

This Is What Whales Are Betting On Johnson & Johnson

A whale with a lot of money to spend has taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 12 strange trades.

Benzinga

Johnson & Johnson Stock Can Fly if It Clears This Level

One resistance level is holding back a more notable rally in Johnson & Johnson stock.

The Street

Read news from The Economist, FT, and more,
with one subscription

Johnson & Johnson Notches Quarterly Beat, Outplaying Exchange-Rate Headwinds

Johnson & Johnson topped third-quarter expectations on Thursday despite exchange-rate challenges, but JNJ stock pared back gains.

Investors Business Daily

Complete Exit For Exxon From Russia, Microsoft's Layoffs, Another Setback For Boeing's Potential 737 MAX 7 Approval, Visa & Mastercard Under FTC Probe: Top Stories Tuesday, Oct. 18

Reuters Exxon Exits Russia Completely After Putin Seizes Company's Properties

Benzinga

Stock Market Today: Stocks Extend Rally On Earnings Power As Bulls Seize Control

With volatility easing and earnings topping forecast, Wall Street is riding one of its strongest three-day rallies of the year heading into the start of Tuesday trading.

The Street

Dow Jones Surges 600 Points As Goldman, J&J Report Earnings; Netflix Earnings Due

The Dow Jones Industrial Average surged Tuesday, as Goldman Sachs and J&J reported earnings results. Netflix earnings are due out late.

Investors Business Daily

Johnson & Johnson Tops Q3 Earnings Forecast, Boosts 2022 Outlook On Pharma Strength

“Our third quarter performance demonstrates our continued strength and resilience across all three of our businesses,” said CEO Joaquin Duato.

The Street

Stocks Power Higher, Goldman Sachs, J&J, Nordstrom, Netflix in Focus - Five Things To Know

Stock futures extend rally as dollar eases, sentiment improves; Goldman Sachs to close out big bank earnings; Johnson & Johnson rises ahead of Q3 earnings; Nordstrom continues takeover defense with CFO departure and Netflix ad service in focus as q3 earnings loom.

The Street

Earnings Season Is Here: Tesla, Netflix, IBM, AT&T And More On Deck - But This Stock Could Be 'Most Important'

The week of Oct. 17 is one of the busiest weeks for publicly traded companies reporting quarterly earnings.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

What Are Whales Doing With Johnson & Johnson

Benzinga

Johnson & Johnson Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 15 strange trades.

St. Louis Post-Dispatch

Editorial: Alex Jones tries to hide his riches from the people whose lives he destroyed

As if to boost the brand of the League of Unrepentant Evildoers, Infowars founder Alex Jones has tried to join the likes of Purdue Pharma, Johnson & Johnson and the National Rifle Association in declaring bankruptcy as a way to evade multimillion-dollar court judgments against him. Jones is in the…

Benzinga

Looking At Johnson & Johnson's Recent Whale Trades

Get all your
news in one place.

100’s of premium titles.
One news app.

Chicago Tribune

Movement in the Tylenol murders: Law enforcement seeks to persuade prosecutors to act on ‘chargeable’ case

CHICAGO — As the 40th anniversary of the 1982 Tylenol murders approaches, investigators are working with prosecutors on a now-or-maybe-never effort to hold a longtime suspect responsible for the poisonings that killed seven people in the Chicago area, the Tribune has learned.

The Street

Novavax Stock Slides As JPMorgan Slashes Price Target, Lowers Rating

JPMorgan analyst Eric Joseph slashed his price target on Novavax by more than $100, to $27 per share.

The Conversation

Action on faulty vaginal mesh took too long, now women struggle to access mesh surgery that works

Last week, Johnson Johnson reached a A$300 million settlement for two class actions brought by Australian women affected by complications from vaginal mesh products.

WEKU

J&J tried to block lawsuits from 40,000 cancer patients. A court wants answers

Critics say a legal maneuver by one of the world's wealthiest corporations could set a precedent, allowing non-bankrupt companies and rich individuals to avoid liability for wrongdoing.

Benzinga

This Is What Whales Are Betting On Johnson & Johnson

A whale with a lot of money to spend has taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 10 strange trades.

The Street

Johnson & Johnson Stock Has Major Support on the Chart

Johnson & Johnson affirmed its full-year outlook and announced a new $5 billion buyback. Should you be a buyer right now?

The Street

Johnson & Johnson Stock Gains After Unveiling $5 Billion Buyback Program, Repeating Profit Targets

"We have the ability to invest in innovation, grow our dividend, execute strategic acquisitions, and take this action to deliver shareholder returns," said CEO Joaquin Duato.

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.